CND Life Sciences, Inc

CND Life Sciences, Inc., based in Scottsdale, AZ, specializes in innovative neurodiagnostic solutions, notably the Syn-One Test, which aids in the diagnosis of Parkinson's disease and related disorders through the detection of alpha-synuclein in skin biopsies. The company is committed to providing high accuracy and reliability in its diagnostic tools, achieving a sensitivity and specificity of 95%.

With over 40,000 patients tested, CND Life Sciences emphasizes a patient-centered approach and the importance of objective evidence in clinical decision-making. Their CLIA-certified and CAP-accredited lab exemplifies a dedication to scientific research and quality in patient care, driven by the philosophy that knowledge is power for both patients and healthcare providers.

Generated from the website